IRMD
IRadimedCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
IRadimed achieves accelerated hospital adoption and wins multiple contracts, expanding recurring consumables revenue and improving scale economics. Positive clinical or regulatory outcomes broaden the addressable market and support meaningful multiple expansion toward the bull target.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Adverse reimbursement or regulatory rulings
Momentum
39
Value
51
Sentiment
55
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $99.00 · Bull $130.00 · Bear $75.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-19 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $118.00
Why
Momentum39 · Δ7d -5.3
Value51 · Δ7d -0.2
Sentiment55 · Δ7d -3.6
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
39
26% active weight
Current posture
7d trendImproving
Δ7d
-5.3
Δ21d
-13.4
Value
51
39% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
+0.0
Sentiment
55
34% active weight
Current posture
7d trendSoftening
Δ7d
-3.6
Δ21d
-5.1
Why this grade
Composite grade C. Momentum 39.3 / Value 50.5 / Sentiment 54.8
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.24B
Beta
1.10
Shares Out
12.78M
P/E (TTM)
59.6
P/S (TTM)
15.53
P/FCF (TTM)
224.78
Rev YoY
+12.7%
EPS YoY
+23.7%
Gross Margin
+76.8%
Op Margin
+30.9%
Net Debt
-$51.16M
Current Ratio
7.13
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology